INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 31, 2020 |
Director
Trans History: 326
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 400 |
| Aug 27, 2020 |
Director
Trans History: 326
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 400 |
| Aug 24, 2020 |
Director
Trans History: 326
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 400 |
| Jul 07, 2020 |
Director
Trans History: 326
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $651.09 | 400 |
| Jan 02, 2015 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 403 | $410.47 | 400 |
| May 06, 2013 |
Director
Trans History: 368
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 400 | $57.11 | 400 |
| Nov 30, 2012 |
VP Regulat Dev & Med Safety
Trans History: 288
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 800 | $183.58 | 400 |
| Mar 15, 2012 |
Director
Trans History: 381
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 400 | $18.61 | 400 |
| Feb 23, 2012 |
Director
Trans History: 368
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 9,600 | $103.51 | 400 |
| Feb 23, 2012 |
Director
Trans History: 368
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 9,600 | $103.51 | 400 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.